Asthma And COPD Drugs Market Opens New Growth Paths in Respiratory Treatment by 2034
The Asthma and COPD Drugs Market is expected to reach US$ 60.17 billion by 2031, registering a CAGR of 6.4% during 2025–2031. Asthma and chronic obstructive pulmonary disease (COPD) are major respiratory conditions requiring long-term disease management, symptom control, and …